Anika Therapeutics (ANIK) Current Deferred Revenue (2010 - 2026)
Anika Therapeutics (ANIK) posted quarterly Current Deferred Revenue of $122000.0 for Q2 2026, down 46.72% quarter-over-quarter from $229000.0 in Q1 2026.
Anika Therapeutics (ANIK) Current Deferred Revenue (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported Current Deferred Revenue for 8 consecutive years, with $122000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Current Deferred Revenue changed N/A year-over-year to $122000.0; the TTM figure through Jun 2026 stood at $122000.0 (changed N/A YoY), while the FY2014 annual figure was $24510.0, down 98.9% from the prior year.
- Current Deferred Revenue fell to $122000.0 in Q2 2026 per ANIK's latest filing, from $229000.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $229000.0 in Q1 2026 and bottomed at $122000.0 in Q2 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Anika Therapeutics | 285.40 Mn | 246.98 Mn | 21.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 122,000.00 |
| Mar 31, 2026 | 229,000.00 |
| Sep 30, 2018 | 52,000.00 |
| Jun 30, 2018 | 74,000.00 |
| Sep 30, 2015 | 33,948.00 |
| Jun 30, 2015 | 35,938.00 |
| Mar 31, 2015 | 139,535.00 |
| Dec 31, 2014 | 24,510.00 |
| Sep 30, 2014 | 12,885.00 |
| Jun 30, 2014 | 15,463.00 |
| Mar 31, 2014 | 46,412.00 |
| Dec 31, 2013 | 2.24 Mn |
| Sep 30, 2013 | 850,067.00 |
| Jun 30, 2013 | 1.53 Mn |
| Mar 31, 2013 | 2.19 Mn |
| Dec 31, 2012 | 5.03 Mn |
| Sep 30, 2012 | 2.87 Mn |
| Jun 30, 2012 | 2.87 Mn |
| Mar 31, 2012 | 2.87 Mn |
| Dec 31, 2011 | 2.50 Mn |